We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
1
Foresite Capital Management IV
California
$60.4M
O
2
OrbiMed
New York
$32.1M +$6.7M +1,100,000 +27%
RCM
3
RA Capital Management
Massachusetts
$26.7M
NI
4
Nextech Invest
Switzerland
$14.6M
BlackRock
5
BlackRock
New York
$14.2M -$358K -58,709 -3%
LCM
6
Lynx1 Capital Management
Puerto Rico
$13.8M +$1.32M +215,833 +11%
VVA
7
Vida Ventures Advisors
Massachusetts
$13.8M
FCMV
8
Foresite Capital Management V
California
$12.3M +$6.7M +1,100,000 +126%
Viking Global Investors
9
Viking Global Investors
Connecticut
$11.4M
Fidelity Investments
10
Fidelity Investments
Massachusetts
$10.3M -$2.69M -441,888 -21%
APM
11
Avidity Partners Management
Texas
$7.25M -$321K -52,700 -4%
WP
12
Woodline Partners
California
$6.81M +$5.5M +902,196 +481%
Citadel Advisors
13
Citadel Advisors
Florida
$6.71M -$182K -29,825 -3%
Vanguard Group
14
Vanguard Group
Pennsylvania
$6.4M +$41.1K +6,746 +0.7%
NHAS
15
Novo Holdings A/S
Denmark
$5.1M
RSCM
16
Rock Springs Capital Management
Maryland
$4.67M
BC
17
Boxer Capital
California
$3.19M
HMC
18
Harvard Management Company
Massachusetts
$3.11M
State Street
19
State Street
Massachusetts
$2.91M +$19.5K +3,199 +0.7%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$2.78M +$83.9K +13,775 +3%
Goldman Sachs
21
Goldman Sachs
New York
$1.37M +$899K +147,479 +205%
Northern Trust
22
Northern Trust
Illinois
$1.32M -$18K -2,961 -1%
Charles Schwab
23
Charles Schwab
California
$881K -$49K -8,047 -5%
Deutsche Bank
24
Deutsche Bank
Germany
$831K +$11.8K +1,930 +1%
AG
25
Artal Group
Luxembourg
$781K